Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

2020360 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov: NCT02369874.

Good health and well-being

Published in: Annals of Oncology

Volume 31, Issue 7, pp. 942-950

Field-Weighted Citation Impact: 20.00